Interview with Hervé Dussart , President, AstraZeneca Turkey
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
Since 1999 with the mission to produce ideas that add value for the life of people spend their lives working for better quality, and performs a lot of research, AstraZeneca, has been undertaking major projects in Turkey within the framework of social responsibility.
AstraZeneca develops prescription drugs, and carry’s out all production and marketing and presentation of these services in the field, as one of the most important international companies in the industry. With global sales on track to reach USD 50 billion by 2025, AstraZeneca provides medications for the areas of cardiology, gastroenterology, oncology, central nervous system, respiratory disease, and diabetes.
Contact
Istanbul
AstraZeneca İlaç San. ve Tic. Ltd. Şti.
Büyükdere Cad. Yapı Kredi Plaza B Blok K:3-4 Levent Istanbul
Istanbul
34330
+90 212 317 23 00
+90 212 317 23 15
http://www.astrazeneca.com/Turkey
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
Ismail Yormaz, vice president & regional director south-east at Recordati, shares the management secrets that have helped him grow Recordati into one of the top pharma companies in Turkey. He…
Sule Mene, co-founder, president and CEO of Mene Health Group, shares with PharmaBoardroom the journey of her company starting as the first government-approved CRO of Turkey, its parallel growth alongside…
Tuğçe Koç reveals how Onko Koçsel was able to quickly grow from an in-licenser to a production-oriented pharmaceutical company with an international reach. She also offers her take on how…
Kazim Dinç, chairman of the board of SURDER and former Minister of Health of Turkey, offers his insights into the Turkish OTC and health products market, highlighting the challenges facing…
Despite the sharp decline in the Turkish lira’s value, the general mood among pharmaceutical executives in Turkey is positive. Rather than being discouraged, they are calling upon their resiliency and…
Acibadem’s Mehmet Ali Aydınlar offers his insights into the Turkish healthcare sector, highlighting Turkey’s burgeoning healthcare tourism industry. He also describes Acıbadem’s focus of growth, globalization and fundamental values that…
Murat Kavrar, country manager at Ekol Turkey, offers readers a look at Ekol’s innovative approach to the logistics sector, emphasizing his company’s R&D capacity and eco-friendly solutions that provide client…
With the construction of state-of-the-art public and private hospitals, Turkey is poised to become a global leader in medical tourism. Turkey has always been a popular tourist destination, given…
Abidin Gulmus, founder and chairman of Gen Ilaç, describes the company’s impressive journey to become Turkey’s principle orphan drug distributor and shares his vision for leveraging the company’s domestic expertise…
In 2016 the Turkish Medicine and Medical Devices Agency (TiTCK) implemented a localisation policy to reduce Turkey’s reliance on imports – a few years later, it has created a young,…
Massimo d’Eufemia, head representative of the European Investment Bank (EIB) in Turkey, highlights the importance of Turkey for the EIB and how the country’s geographic position and key economic role…
Tahsin Yüksel, general manager of Teva Turkey, analyzes the strategic importance of pharmaceutical branding in Turkey, shares the story of Teva’s adaptation to the unique market needs, and offers his…
See our Cookie Privacy Policy Here